Literature DB >> 2370389

Cytotoxicity of human eosinophil granule major basic protein to human nasal sinus mucosa in vitro.

K Hisamatsu1, T Ganbo, T Nakazawa, Y Murakami, G J Gleich, K Makiyama, H Koyama.   

Abstract

The toxic effects of the human eosinophil granule major basic protein (MBP), reduced and alkylated, were studied on human nasal mucosa in vitro. With a microscope coupled with a television monitor (magnification x 2500) and videotape recorder, we investigated the effects of MBP on the mucosa and the ciliary activity of single cells. In nasal mucosal specimens from normal individuals, MBP, 5 mumol/L and 10 mumol/L, significantly inhibited (p less than 0.01) ciliary activity by 4 and 1 hours of exposure, respectively. At these same MBP concentrations, the mucosal surface profiles were altered by 4 hours of exposure, and ciliostasis was 75% to 100% complete by 9 and 6 hours, respectively. In a mucosal specimen from a patient with nasal allergy, 1 mumol/L of MBP significantly inhibited (p less than 0.01) ciliary activity by 1 hour; alteration of the mucosal surface profile appeared by 3 hours of exposure, and ciliostasis was 75% to 100% by 13 hours. Similar alterations of the mucosal surface profile were observed with specimens from a second patient with allergies; in contrast, 1 mumol/L of MPB had no effect on specimens from a nonallergic patient. These results indicate that MBP damages human upper respiratory epithelium, causing ciliostasis and alteration of the epithelial surface at concentrations likely achieved in vivo. Furthermore, the mucosal specimens from two allergic patients were damaged by concentrations of MBP that had no effect on mucosal specimens from a normal individual.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2370389     DOI: 10.1016/s0091-6749(05)80123-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  15 in total

1.  Epigenetics of chronic rhinosinusitis and the role of the eosinophil.

Authors:  Kristin A Seiberling; Christopher A Church; Jason L Herring; Lawrence C Sowers
Journal:  Int Forum Allergy Rhinol       Date:  2011-08-26       Impact factor: 3.858

2.  Macrophage-mediated candidacidal activity is augmented by exposure to eosinophil peroxidase: a paradigm for eosinophil-macrophage interaction.

Authors:  D L Lefkowitz; J A Lincoln; K R Howard; R Stuart; S S Lefkowitz; R C Allen
Journal:  Inflammation       Date:  1997-04       Impact factor: 4.092

Review 3.  Is rhinosinusitis a cause of asthma?

Authors:  Brian A Smart
Journal:  Clin Rev Allergy Immunol       Date:  2006-06       Impact factor: 8.667

Review 4.  The role of ubiquitous airborne fungi in chronic rhinosinusitis.

Authors:  Jens U Ponikau; David A Sherris; Gail M Kephart; Cheryl Adolphson; Hirohito Kita
Journal:  Clin Rev Allergy Immunol       Date:  2006-06       Impact factor: 8.667

Review 5.  Changing roles of eosinophils in health and disease.

Authors:  Glenn T Furuta; F Dan Atkins; Nancy A Lee; James J Lee
Journal:  Ann Allergy Asthma Immunol       Date:  2014-05-01       Impact factor: 6.347

Review 6.  Biology of the eosinophil.

Authors:  Carine Blanchard; Marc E Rothenberg
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

7.  Distribution of major basic protein on human airway following in vitro eosinophil incubation.

Authors:  Ailing Xue; John Wang; Gary C Sieck; Mark E Wylam
Journal:  Mediators Inflamm       Date:  2010-03-22       Impact factor: 4.711

Review 8.  A new dawn for eosinophils in the tumour microenvironment.

Authors:  Sharon Grisaru-Tal; Michal Itan; Amy D Klion; Ariel Munitz
Journal:  Nat Rev Cancer       Date:  2020-07-16       Impact factor: 60.716

9.  The relationship between eosinophilia and airway remodelling in mild asthma.

Authors:  S J Wilson; H M Rigden; J A Ward; M Laviolette; N N Jarjour; R Djukanović
Journal:  Clin Exp Allergy       Date:  2013-12       Impact factor: 5.018

Review 10.  Inflammatory mechanisms and remodeling in chronic rhinosinusitis and nasal polyps.

Authors:  Ruby Pawankar; Manabu Nonaka
Journal:  Curr Allergy Asthma Rep       Date:  2007-06       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.